Fig. 1From: The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946Viability percentage of Leishmania major promastigotes treated with different concentrations of Lucilia sericata larval saliva and hemolymph compared with glucantime. a %Viability of L. major promastigotes treated with different concentrations of larval products at 24Â h. b %Viability of L. major promastigotes treated with larval products at 48Â h. c %Viability of L. major promastigotes treated with larval products at 72Â h. d %Viability of L. major promastigotes treated with larval products at 96Â hBack to article page